HoloCare: Pioneering AI and 3D Surgical Planning

With Medical Device Regulation (MDR) approval and ISO 13485 certification now in place, HoloCare is set for rapid commercial expansion. We are launching a €5 million investment round to accelerate our growth and establish ourselves as a leader in AI-powered, cloud-based preoperative planning.

We are seeking strategic investment partners to support our next phase of growth, as we expand commercially across Europe and enter the US market.

Where: Advokatfirma DLA Piper Norway, Bryggegata 6, 0250 Oslo
When: March 19th at 12.00-13.30

Sign up for the event here

For over eight years, our founding partners – Oslo University Hospital (OUS), Sopra Steria and Inven2 – have driven innovation in mixed-reality surgical planning. Now, with a validated and rapidly scaling technology, HoloCare is positioned for international market adoption.

Why Invest?

• Be part of a high-growth MedTech company at a critical scaling point.
• MDR approval unlocks commercial opportunities across Europe and beyond.
• Proven impact: HoloCare’s technology has already made previously inoperable surgeries possible.
• A booming market: AI-driven surgical planning is at the forefront of a €190 billion healthtech revolution.
• Network with industry leaders, clinicians, and key investors shaping the future of digital surgery.

This is an exclusive opportunity to invest in cutting-edge MedTech with regulatory approval, a strong partner network, and a clear path to scale.

Secure your spot today and explore how you can invest in the future of surgery!

Sign up for the event here

We look forward to welcoming you on March 19th at 12:00 at Aker Brygge.

If you have any inquiries, please contact

Alison Sundset
HoloCare CEO
‍alison.sundset@holocare.com

Jahn Otto Andersen
Innovation Director
‍jahn-otto.andersen@holocare.com